Skip to main content

Table 3 Susceptibility pattern of bacterial isolates form pediatric patients with otitis media in Addis Ababa, Ethiopia, Jan 2013- Jun 2014 (n = 196)

From: Isolation and antimicrobial drug susceptibility pattern of bacterial pathogens from pediatric patients with otitis media in selected health institutions, Addis Ababa, Ethiopia: a prospective cross-sectional study

Isolated Pathogen

Total

AMX

AMP

AUG

GEN

CHL

CIP

CLN

DOX

TOB

ERY

CEF

CTX

P

SXT

CAZ

S. aureus

16

4

2

13

1

6

8

10

5

 

4

13

 

1

2

 

P. aeruginosa

11

1

1

9

2

4

7

 

5

10

2

9

8

 

2

9

Viridians strept.

10

4

2

10

1

5

10

7

7

 

4

8

 

1

1

 

S. pneumoniae

9

4

4

8

4

6

7

5

6

 

5

8

 

3

3

 

Acinetobacter spp

8

1

1

8

1

3

6

3

4

5

2

4

6

1

1

6

P. mirabilis

8

  

6

2

3

6

  

6

 

5

7

 

3

7

S. pyogenes

8

8

8

8

4

6

8

6

8

 

5

8

 

8

2

 

E. coli

7

  

6

1

3

6

  

6

 

6

7

 

1

7

Klebsiella spp

7

  

4

0

0

6

  

5

 

4

7

 

2

7

Enterococcus spp

6

0

1

5

0

2

5

3

3

3

3

6

 

0

1

 

M. catarrhalis*

6

2

2

6

3

2

6

2

6

 

3

3

 

2

2

 

Enterobacter spp

3

  

3

1

2

3

  

3

 

3

3

 

1

3

Citrobacter spp

2

  

2

0

1

2

  

2

 

2

2

 

1

2

  1. AMX Amoxicillin, GEN Gentamycin, CAZ Ceftazidime, CHL Chloramphenicol, CIP Ciprofloxacin, CLN Clindamycin, AUG Augmentin, DOX Doxycycline, TOB Tobramycin, ERY Erythromycin, CEF Cefuroxime, CTX Cefotaxime, AMP Ampicillin, P Penicillin G, SXT trimethoprim- sulfamethoxazole
  2. *The antimicrobial susceptibility pattern of M. catarrhalis was based the criteria of British Society of Antimicrobial Chemotherapy [Howe and Andrews, 2012], whereas Clinical Laboratory Standards Institute [CLSI, 2013] was used for other isolates
Back to article page

BMC Ear, Nose and Throat Disorders

ISSN: 1472-6815

Contact us